McKesson Co. Expected to Earn Q1 2025 Earnings of $7.19 Per Share (NYSE:MCK)

McKesson Co. (NYSE:MCKFree Report) – Stock analysts at Leerink Partnrs boosted their Q1 2025 EPS estimates for shares of McKesson in a note issued to investors on Monday, July 8th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $7.19 per share for the quarter, up from their prior forecast of $7.18. The consensus estimate for McKesson’s current full-year earnings is $31.53 per share. Leerink Partnrs also issued estimates for McKesson’s Q2 2025 earnings at $7.78 EPS and FY2028 earnings at $45.39 EPS.

MCK has been the topic of a number of other research reports. StockNews.com cut McKesson from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 2nd. Barclays increased their price target on shares of McKesson from $571.00 to $596.00 and gave the company an “overweight” rating in a report on Wednesday, May 8th. Wells Fargo & Company upped their target price on McKesson from $502.00 to $551.00 and gave the company an “equal weight” rating in a research report on Thursday, May 9th. Evercore ISI lifted their price target on McKesson from $600.00 to $660.00 and gave the stock an “outperform” rating in a report on Tuesday. Finally, Citigroup increased their price objective on McKesson from $575.00 to $620.00 and gave the stock a “buy” rating in a research report on Tuesday, April 30th. Two research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, McKesson presently has an average rating of “Moderate Buy” and an average price target of $596.00.

Read Our Latest Report on MCK

McKesson Stock Performance

Shares of MCK stock opened at $586.82 on Tuesday. The firm’s 50-day moving average is $574.01 and its 200-day moving average is $532.72. The stock has a market cap of $76.25 billion, a price-to-earnings ratio of 26.22, a PEG ratio of 1.38 and a beta of 0.45. McKesson has a 52-week low of $395.30 and a 52-week high of $612.17.

McKesson (NYSE:MCKGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $6.18 EPS for the quarter, missing the consensus estimate of $6.34 by ($0.16). The company had revenue of $76.36 billion for the quarter, compared to analyst estimates of $79.32 billion. McKesson had a net margin of 0.97% and a negative return on equity of 245.88%. The business’s revenue for the quarter was up 10.8% on a year-over-year basis. During the same period last year, the company posted $7.19 earnings per share.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, July 1st. Shareholders of record on Monday, June 3rd were given a $0.62 dividend. This represents a $2.48 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date was Monday, June 3rd. McKesson’s dividend payout ratio is presently 11.08%.

Insider Transactions at McKesson

In other McKesson news, Director Maria Martinez sold 483 shares of the business’s stock in a transaction on Friday, June 7th. The shares were sold at an average price of $585.88, for a total transaction of $282,980.04. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other McKesson news, Director Maria Martinez sold 483 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $585.88, for a total value of $282,980.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Wednesday, July 3rd. The stock was sold at an average price of $580.92, for a total transaction of $2,180,192.76. Following the transaction, the chief executive officer now owns 86,092 shares in the company, valued at approximately $50,012,564.64. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 29,567 shares of company stock valued at $16,691,841. 0.11% of the stock is currently owned by insiders.

Hedge Funds Weigh In On McKesson

A number of hedge funds have recently made changes to their positions in MCK. JPMorgan Chase & Co. increased its position in McKesson by 1.1% during the 1st quarter. JPMorgan Chase & Co. now owns 4,362,837 shares of the company’s stock valued at $2,342,190,000 after purchasing an additional 46,659 shares during the period. Norges Bank bought a new position in McKesson during the fourth quarter worth $1,024,140,000. Putnam Investments LLC lifted its holdings in McKesson by 3.2% in the fourth quarter. Putnam Investments LLC now owns 1,997,963 shares of the company’s stock valued at $925,017,000 after buying an additional 62,242 shares during the period. Swedbank AB acquired a new stake in McKesson during the 1st quarter worth about $669,326,000. Finally, Boston Partners raised its position in shares of McKesson by 4.1% in the 1st quarter. Boston Partners now owns 1,183,829 shares of the company’s stock worth $635,763,000 after acquiring an additional 47,140 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors.

McKesson Company Profile

(Get Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Further Reading

Earnings History and Estimates for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.